154 related articles for article (PubMed ID: 37060916)
1. Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries.
Pirenne F; Floch A; Diop S
Lancet Haematol; 2023 Jun; 10(6):e468-e476. PubMed ID: 37060916
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo.
Kambale-Kombi P; Djang'eing'a RM; Alworong'a Opara JP; Minon JM; Sepulchre E; Bours V; Floch A; Pirenne F; Tshilumba CK; Batina-Agasa S
Transfus Med; 2023 Apr; 33(2):137-146. PubMed ID: 36377544
[TBL] [Abstract][Full Text] [Related]
3. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
Shih AW; Yan MTS; Elahie AL; Barty RL; Liu Y; Berardi P; Azzam M; Siddiqui R; Parvizian MK; Mcdougall T; Heddle NM; Al-Habsi KS; Goldman M; Cote J; Athale U; Verhovsek MM
Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
[TBL] [Abstract][Full Text] [Related]
4.
Bernit E; Jean E; Marlot B; Laget L; Izard C; Dettori I; Beley S; Gautier I; Agouti I; Frassati C; Pedini P; Picard C; Paganini J; Chiaroni J; Di Cristofaro J
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686397
[TBL] [Abstract][Full Text] [Related]
5. [Transfusion and sickle cell disease].
Boulat C
Transfus Clin Biol; 2013 May; 20(2):68-71. PubMed ID: 23597585
[TBL] [Abstract][Full Text] [Related]
6. Extended red blood cell matching for all transfusion recipients is feasible.
van Sambeeck JHJ; van der Schoot CE; van Dijk NM; Schonewille H; Janssen MP
Transfus Med; 2022 Jun; 32(3):221-228. PubMed ID: 34845765
[TBL] [Abstract][Full Text] [Related]
7. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
Fasano RM; Chou ST
Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
[TBL] [Abstract][Full Text] [Related]
8. Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions.
Zheng Y; Maitta RW
Transfus Med; 2016 Jun; 26(3):225-30. PubMed ID: 27197689
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Balbuena-Merle R; Hendrickson JE
Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
Moncharmont P
Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
[TBL] [Abstract][Full Text] [Related]
11. Relevance of blood groups in transfusion of sickle cell disease patients.
Noizat-Pirenne F
C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
[TBL] [Abstract][Full Text] [Related]
12. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
Regalado-Artamendi I; Pérez-Corral AM; García-Morín M; Cela E; Beléndez C; Bardón-Cancho EJ; Pérez-Rus G; Pérez-Sánchez I; Pascual C; Monsalvo S; Falero C; Díez-Martín JL; Anguita J
Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
[TBL] [Abstract][Full Text] [Related]
13. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
Rodrigues C; Sell AM; Guelsin GAS; Higa TT; Pagliarini E Silva S; Macedo LC; Sippert EÂ; de Alencar JB; Zanette Â; Acorsi CRL; Castilho L; Visentainer JEL
Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
[TBL] [Abstract][Full Text] [Related]
14. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review.
da Cunha Gomes EG; Machado LAF; de Oliveira LC; Neto JFN
Transfus Med; 2019 Jun; 29(3):149-161. PubMed ID: 29845661
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
[TBL] [Abstract][Full Text] [Related]
17. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
18. O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients.
Luyten U; Peeraer S; Pirlet C; Khaouch Y; Streel C; Deneys V
Transfus Clin Biol; 2023 Nov; 30(4):402-409. PubMed ID: 37453488
[TBL] [Abstract][Full Text] [Related]
19. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
20. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
